There is a wealth of evidence suggesting that CIN is a contributing factor to the aggressiveness of a subset of otherwise lower-grade IDH-mutant astrocytomas, however because CIN is a dynamic and ongoing process and a single biopsy or resection specimen represents only a snapshot of the temporal and spatial molecular evolution of the neoplasm, detection may be difficult and impractical in many clinical settings [35, 36]. Here, IDH1 is linked to astrocytoma (excluding glioblastoma).